Desjardins, CTS Santé to invest $5 mln in med-tech startups
Desjardins–Innovatech Fund and Campus des technologies de la santé (CTS Santé) have launched a new funding program focused on startups in the medical technologies industry. Over the next five years, the partners plan to invest $5 million to commercialize the products and services of emerging businesses and help them enter new markets. Two companies have already been backed by the program: Emovi, a specialist in knee function medical solutions; and Biomomentum, a maker of devices for the biomechanical evaluation of biomaterials and cartilage. Both Emovi and Biomomentum are based in Laval, Québec.
18 November 2015•4 mins read
